First, due to the retrospective nature of this study, we could not examine the impact of the reported SNPs, such as PBPLA3, TM6SF2, et al., on HCC development in IFN- and DAA-SVR HCV patients [32]. Here, TM6SF2 is linked to hepatocellular carcinoma.